
CDSCO Panel Asks Takeda to Submit Full Phase III Data on Dengue Tetravalent Vaccine
CDSCO Panel Asks Takeda to Submit Full Phase III Data on Dengue Tetravalent Vaccine We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link